Skip to
  1. Homepage
  2. Research and trials
  3. Clinical trials
Search by disease/gene

Search by disease/gene

*
(*) mandatory field


 

Other search option(s)

7 Result(s)

Caption : Recruiting trial = Recruiting trial ; Ongoing trial = Ongoing trial

    • FRANCE
    • RHONE-ALPES
    • NOT YET IDENTIFIED - FR
    • Recruiting trial Ongoing trial
    • An exploratory, open label, non-randomized, within-patient multiple dose-escalation safety, tolerability, PK and efficacy trial of RAD001 (Everolimus) in patients with lymphangioleiomyomatosis (Phase II) - FR
    • Not yet identified - FR
    • More details
    • FRANCE
    • RHONE-ALPES
    • NOT YET IDENTIFIED - FR
    • An exploratory, open label, non-randomized, within-patient multiple dose-escalation safety, tolerability, PK and efficacy trial of RAD001 (everolimus) in patients with Lymphangioleiomyomatosis - FR
    • Not yet identified - FR
    • More details
    • GERMANY
    • Bayern
    • MÜNCHEN
    • Ongoing trial
    • EXIST-2: A randomized, double-blind, placebo-controlled study of RAD001 in the treatment of Angiomyolipoma in patients with either Tuberous Sclerosis Complex or Sporadic Lymphangioleiomyomatosis (Phase III)
    • LMU Klinikum der Universität München - Campus Innenstadt
    • Nephrologisches Zentrum
    • More details
    • GERMANY
    • Berlin
    • BERLIN
    • Ongoing trial
    • EXIST-2: A randomized, double-blind, placebo-controlled study of RAD001 in the treatment of Angiomyolipoma in patients with either Tuberous Sclerosis Complex or Sporadic Lymphangioleiomyomatosis (Phase III)
    • Charité - Universitätsmedizin Berlin (CCM)
    • Medizinische Klinik mit Schwerpunkt Nephrologie
    • More details
    • ITALY
    • LOMBARDIA
    • MILANO
    • Recruiting trial Ongoing trial
    • An exploratory, open label, non-randomized, within-patient multiple dose-escalation safety, tolerability, PK and efficacy trial of RAD001 (Everolimus) in patients with lymphangioleiomyomatosis (Phase II) - IT
    • Ospedale San Giuseppe
    • U. O. di Pneumologia
    • More details
    • SPAIN
    • Cataluña
    • BARCELONA
    • Ongoing trial
    • EXIST-2: A Randomized, Double-blind, Placebo-controlled Study of RAD0001 in the Treatment of Angiomyolipoma in Patients With Either Tuberous Sclerosis Complex (TSC) or Sporadic Lymphangioleiomyomatosis (LAM) - ES (Phase III)
    • Fundació Puigvert
    • Servicio de Nefrología
    • More details
    • UNITED KINGDOM
    • East Sussex
    • BRIGHTON
    • Ongoing trial
    • CCRN 089 (Angiomyolipoma): A randomised, double-blind, placebo-controlled study of RAD001 in the treatment of Angiomyolipoma in patients with either Tuberous Sclerosis Complex (TSC) or Sporadic Lymphangioleiomyomatosis (LAM), phase III
    • Royal Sussex County Hospital
    • Sussex Kidney Unit
    • More details